Amicus Therapeutics, Inc (FOLD) Covered Calls

Amicus Therapeutics, Inc covered calls Amicus Therapeutics, a clinical-stage biopharmaceutical company is focused on the discovery, development and commercialization of a new class of orally-administered, small molecule drugs, for the treatment of a range of human genetic diseases.

You can sell covered calls on Amicus Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for FOLD (prices last updated Fri 4:16 PM ET):

Amicus Therapeutics, Inc (FOLD) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
12.18 +0.31 11.80 13.91 1.5M -6.3 2.7B
Covered Calls For Amicus Therapeutics, Inc (FOLD)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Jun 21 12 0.55 13.36 -10.2% -128.4%
Jul 19 12 0.90 13.01 -7.8% -49.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Amicus Therapeutics, Inc. is a biopharmaceutical company focuses on the discovery, development and commercialization of orally administered, small molecule drugs known as pharmacological chaperones for the treatment of rare diseases, pharmacological chaperones are a novel, first-in-class approach to treating a broad range of diseases, including lysosomal storage disorders and diseases of neurodegeneration. Amicus develops pharmacological chaperones oral therapies that bind to and stabilize the affected proteins, restoring their shape, proper trafficking, and biological activity. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.